|
Advertising
Customer Service
Register
|
MORE FROM NJBIZ
PEOPLE WHO READ THIS...
Also read these stories:
|
||||||||||
By João-Pierre Ruth
The nutraceuticals developer plans to use the funding to launch its Surgex nutritional beverage product line for the domestic and international sports market in the fourth quarter. Millennium’s flagship product line is branded as Resurgex, with claims of helping reduce fatigue and stress while supporting the immune system.
The products will also be marketed to cancer patients through the P4 Healthcare oncology network, which includes private oncology medical practices. Millennium Biotechnology shares were unchanged at $0.18 in late-morning trading.